Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer

por Soleimani Dodaran, Maryam, Borgoni, Simone, Sofyalı, Emre, Verschure, Pernette J., Wiemann, Stefan, Moerland, Perry D., van Kampen, Antoine H. C.
Publicado 2020

Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets

por Beumers, Lukas, Vlachavas, Efstathios-Iason, Borgoni, Simone, Schwarzmüller, Luisa, Penso-Dolfin, Luca, Michels, Birgitta E., Sofyali, Emre, Burmester, Sara, Heiss, Daniela, Wilhelm, Heike, Yarden, Yosef, Helm, Dominic, Will, Rainer, Goncalves, Angela, Wiemann, Stefan
Publicado 2023

Time-Resolved Profiling Reveals ATF3 as a Novel Mediator of Endocrine Resistance in Breast Cancer

por Borgoni, Simone, Sofyalı, Emre, Soleimani, Maryam, Wilhelm, Heike, Müller-Decker, Karin, Will, Rainer, Noronha, Ashish, Beumers, Lukas, Verschure, Pernette J., Yarden, Yosef, Magnani, Luca, van Kampen, Antoine H.C., Moerland, Perry D., Wiemann, Stefan
Publicado 2020